Yes, Smith & Nephew plc has a long-standing corporate history of rewarding its shareholders by distributing regular semi-annual cash dividends. The multinational medical technology enterprise typically declares an interim dividend and a final full-year dividend supported by its robust operational cash flows, solid balance sheet discipline, and steady profitability across its orthopedic, sports medicine, and advanced wound management divisions.